{{Rsnum
|rsid=2494251
|Chromosome=1
|position=159311361
|Orientation=plus
|GMAF=0.3108
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 52.2 | 29.2
| HCB | 5.1 | 43.1 | 51.8
| JPT | 7.1 | 46.9 | 46.0
| YRI | 0.0 | 6.2 | 93.8
| ASW | 1.8 | 19.3 | 78.9
| CHB | 5.1 | 43.1 | 51.8
| CHD | 8.3 | 32.4 | 59.3
| GIH | 10.9 | 41.6 | 47.5
| LWK | 0.0 | 11.9 | 88.1
| MEX | 8.6 | 39.7 | 51.7
| MKK | 3.8 | 31.4 | 64.7
| TSI | 16.7 | 50.0 | 33.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19372141
|Title=Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}